BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33539357)

  • 41. Latent class models for medical diagnostic tests in multicenter trials.
    Mori J; Kano Y; Yoshizaki M; Fukinbara S
    Stat Med; 2013 Dec; 32(29):5091-105. PubMed ID: 24038422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intestinal schistosomiasis: Can a urine sample decide the infection?
    Diab RG; Tolba MM; Ghazala RA; Abu-Sheasha GA; Webster BL; Mady RF
    Parasitol Int; 2021 Feb; 80():102201. PubMed ID: 33010472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic test accuracy of nutritional tools used to identify undernutrition in patients with colorectal cancer: a systematic review.
    Håkonsen SJ; Pedersen PU; Bath-Hextall F; Kirkpatrick P
    JBI Database System Rev Implement Rep; 2015 May; 13(4):141-87. PubMed ID: 26447079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STARD-BLCM: Standards for the Reporting of Diagnostic accuracy studies that use Bayesian Latent Class Models.
    Kostoulas P; Nielsen SS; Branscum AJ; Johnson WO; Dendukuri N; Dhand NK; Toft N; Gardner IA
    Prev Vet Med; 2017 Mar; 138():37-47. PubMed ID: 28237234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low accuracy of Bayesian latent class analysis for estimation of herd-level true prevalence under certain disease characteristics-An analysis using simulated data.
    McAloon CG; Doherty ML; Whyte P; Verdugo C; Toft N; More SJ; O'Grady L; Green MJ
    Prev Vet Med; 2019 Jan; 162():117-125. PubMed ID: 30621890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostics for schistosomiasis in Africa and Arabia: a review of present options in control and future needs for elimination.
    Stothard JR; Stanton MC; Bustinduy AL; Sousa-Figueiredo JC; Van Dam GJ; Betson M; Waterhouse D; Ward S; Allan F; Hassan AA; Al-Helal MA; Memish ZA; Rollinson D
    Parasitology; 2014 Dec; 141(14):1947-61. PubMed ID: 25158604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarker validation with an imperfect reference: Issues and bounds.
    Emerson SC; Waikar SS; Fuentes C; Bonventre JV; Betensky RA
    Stat Methods Med Res; 2018 Oct; 27(10):2933-2945. PubMed ID: 28166709
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach.
    Garrett ES; Eaton WW; Zeger S
    Stat Med; 2002 May; 21(9):1289-307. PubMed ID: 12111879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A sequential classification rule based on multiple quantitative tests in the absence of a gold standard.
    Zhang J; Zhang Y; Chaloner K; Stapleton JT
    Stat Med; 2016 Apr; 35(8):1359-72. PubMed ID: 26522690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A global sensitivity analysis of performance of a medical diagnostic test when verification bias is present.
    Kosinski AS; Barnhart HX
    Stat Med; 2003 Sep; 22(17):2711-21. PubMed ID: 12939781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Reference standards in diagnostic research: problems and solutions].
    de Groot JA; Reitsma JB; Moons K
    Ned Tijdschr Geneeskd; 2014; 159():A7202. PubMed ID: 25589276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of weighted kappa coefficients of multiple binary diagnostic tests done on the same subjects.
    Roldán Nofuentes JA; Luna del Castillo JD
    Stat Med; 2010 Sep; 29(20):2149-65. PubMed ID: 20809538
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using pseudogold standards and latent-class analysis in combination to evaluate the accuracy of three diagnostic tests.
    Nérette P; Stryhn H; Dohoo I; Hammell L
    Prev Vet Med; 2008 Jul; 85(3-4):207-25. PubMed ID: 18355935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of sensitivity and specificity of multiple repeated binary tests without a gold standard.
    Wang C; Hanson TE
    Stat Med; 2019 Jun; 38(13):2381-2390. PubMed ID: 30815919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Bayesian approach to simultaneously adjusting for verification and reference standard bias in diagnostic test studies.
    Lu Y; Dendukuri N; Schiller I; Joseph L
    Stat Med; 2010 Oct; 29(24):2532-43. PubMed ID: 20799249
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A geostatistical framework for combining spatially referenced disease prevalence data from multiple diagnostics.
    Amoah B; Diggle PJ; Giorgi E
    Biometrics; 2020 Mar; 76(1):158-170. PubMed ID: 31449327
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic methods I: sensitivity, specificity, and other measures of accuracy.
    van Stralen KJ; Stel VS; Reitsma JB; Dekker FW; Zoccali C; Jager KJ
    Kidney Int; 2009 Jun; 75(12):1257-1263. PubMed ID: 19340091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic test analyses in search of their gold standard: latent class analyses with random effects.
    Goetghebeur E; Liinev J; Boelaert M; Van der Stuyft P
    Stat Methods Med Res; 2000 Jun; 9(3):231-48. PubMed ID: 11084706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bayesian latent class analysis when the reference test is imperfect.
    Cheung A; Dufour S; Jones G; Kostoulas P; Stevenson MA; Singanallur NB; Firestone SM
    Rev Sci Tech; 2021 Jun; 40(1):271-286. PubMed ID: 34140724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New diagnostic tools in schistosomiasis.
    Utzinger J; Becker SL; van Lieshout L; van Dam GJ; Knopp S
    Clin Microbiol Infect; 2015 Jun; 21(6):529-42. PubMed ID: 25843503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.